Related Experiment Videos
Basic treatment planning parameters for a 90Sr / 90Y source train used in endovascular brachytherapy
Christian Kirisits1, Daniel Berger, Rainer Schmid
1Department of Radiotherapy and Radiobiology, Medical University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna. Christian.Kirisits@akhwien.at
Zeitschrift Fur Medizinische Physik
|October 7, 2004
Summary
This study validates dose calculations for endovascular brachytherapy using the Novoste Betacath system. Findings emphasize safety margins for accurate treatment planning and optimal intervention lengths.
Area of Science:
- Medical Physics
- Radiation Oncology
- Brachytherapy
Background:
- Endovascular brachytherapy treatment planning often relies on protocols and manufacturer guidelines.
- Accurate dose distribution and geometrical uncertainties are crucial for effective treatment planning.
Purpose of the Study:
- To validate Monte Carlo dose calculations for endovascular brachytherapy with the Novoste Betacath system.
- To determine optimal safety margins and treatable lengths based on dose profiles and uncertainties.
Main Methods:
- Monte Carlo algorithms were used to calculate dose distribution around a 90Sr seed train.
- Calculated dose profiles were verified using film dosimetry.
- Geometrical uncertainties were assessed through retrospective analysis of 51 patient treatments.
Main Results:
- Calculated radial dose profiles closely matched measured values.
- A minimum safety margin of 10 mm is recommended between Intervention Length and Reference Isodose Length.
- Maximum treatable intervention lengths were determined as 25 mm (40 mm source) and 45 mm (60 mm source).
Conclusions:
- The study provides validated dose distribution data for clinical endovascular brachytherapy.
- Established safety margins and treatable lengths enhance treatment planning accuracy.
- Findings support evidence-based guidelines for endovascular brachytherapy procedures.